PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 0.87 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NantHealth Inc | NH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.87 | 0.89 | 0.85 | 0.89 | 0.87 | 19:59:41 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.7973 | 0.99 | 0.1927 | 19.46% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 310 | 81,607 | $ 0.8713367 | $ 71,107 | 82,403 | 0.45 - 1.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:42 | formt | 639 | $ 0.87 | USD |
NantHealth Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 96.24M | 110.62M | $ -192.15M | -1.75 | - | 109.87M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 2.00 | 0.70% |
NantHealth News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/12/2019 | 14:15 | Business Wire | NantHealth Announces FDA Marketing Authorization of Omics.. |
| 11/12/2019 | 08:00 | Business Wire | NantHealth Announces FDA Marketing Authorization of Omics.. |
| 11/08/2019 | 09:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/08/2019 | 06:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/08/2019 | 06:01 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/07/2019 | 16:39 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/07/2019 | 16:15 | Business Wire | NantHealth Reports 2019 Third-Quarter Financial Results |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.745 | 0.89 | 0.65 | 0.7503857 | 270,084 | 0.125 | 16.78% |
| 1 Month | 0.7348 | 0.89 | 0.51 | 0.7403714 | 101,282 | 0.1352 | 18.4% |
| 3 Months | 0.56 | 0.925 | 0.45 | 0.7034892 | 112,574 | 0.31 | 55.36% |
| 6 Months | 0.63 | 0.925 | 0.45 | 0.624216 | 126,821 | 0.24 | 38.1% |
| 1 Year | 1.37 | 1.96 | 0.45 | 0.8410598 | 190,155 | -0.50 | -36.5% |
| 3 Years | 11.54 | 13.12 | 0.45 | 3.13 | 172,466 | -10.67 | -92.46% |
| 5 Years | 16.11 | 21.00 | 0.45 | 4.53 | 170,599 | -15.24 | -94.6% |
NantHealth Description
| NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision making. The company provides cancer care solutions, provide solutions, and payer solutions. |
